Wallaby Medical

Wallaby Medical is a global medical technology company focused on developing and commercializing neurovascular interventional products for stroke treatment and related conditions. Founded in 2015, the company operates from Laguna Hills, California, and Shanghai, China, employing over 250 people worldwide. The product portfolio includes the Avenir® Coil System for treating intracranial aneurysms, the Esperance Aspiration Catheter for ischemic stroke procedures, and the Esperance Distal Access Catheter for neurovascular interventions. Wallaby Medical markets its products in over 30 countries, including major markets like the U.S., China, Europe, and Japan. The acquisition of phenox GmbH in 2022 enhanced its product offerings and expanded its reach to more than 60 countries. Wallaby Medical is committed to quality assurance and adheres to international standards, with its Shanghai facility certified by BSI. The company aims to be a leader in stroke care solutions, focusing on innovation and clinical efficacy. It is privately held, with estimated revenues around $11.9 million and has raised over $65 million in funding.

• Employees 29
• Founded 2015